Product Review Opportunity for: Weliva® Active Iron 25mg
Iron deficiency remains one of the most common nutritional deficiencies worldwide, affecting more than 2.2 billion people.1 In Canada, an estimated 7% to 10.5% of the population is iron deficient, while 18% to 29% of women aged 19 to 50 years are at increased risk of developing iron deficiency.2
Although oral iron supplements are widely available, many individuals struggle to restore adequate iron levels because conventional iron therapies are often poorly tolerated.3
Active Iron is a new iron supplement on the Canadian market, clinically proven to help increase iron and energy levels in individuals with iron deficiency.
So, if you think that you may be at risk of having low iron levels without being anemic, maybe you'd like to try Active Iron 25mg! If so, please complete the short survey below to evaluate if you are an appropriate candidate.
Please note that this product should be taken for 10 days. Only individuals who are currently using an iron supplement (not to treat anemia) or who need to increase their iron intake should participate in this program.
If you are not currently using an iron supplement or do not need to increase your iron levels, please do not apply to this product review opportunity.
This survey is to help evaluate potential to participate in this program and has not been clinically validated. It is not intended to diagnose iron deficiency or any other medical condition and should not replace consultation with a healthcare professional. If you have symptoms or concerns, please speak with your healthcare provider.
Opportunity is open to residents of Canada only.
WELIVA is a registered trademark of Norwell Consumer Healthcare Inc.
The Active Iron logos are trademarks of Solvotrin Therapeutics Ltd, used under license.
1. Lopez et al., Iron Deficiency Anaemia, Lancet 2016; 387:907-16
2. Cooper, M. et al. (2023). Population iron status in Canada: Results from the Canadian Health Measures Survey 2012–2019.
3. Tolkien, Z. et al. (2015). Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta Analysis. PLOS ONE. DOI:10.1371/journal.pone.0117383
You must be logged in to complete this.
Product Review Opportunity for: Weliva® Active Iron 25mg
Iron deficiency remains one of the most common nutritional deficiencies worldwide, affecting more than 2.2 billion people.1 In Canada, an estimated 7% to 10.5% of the population is iron deficient, while 18% to 29% of women aged 19 to 50 years are at increased risk of developing iron deficiency.2
Although oral iron supplements are widely available, many individuals struggle to restore adequate iron levels because conventional iron therapies are often poorly tolerated.3
Active Iron is a new iron supplement on the Canadian market, clinically proven to help increase iron and energy levels in individuals with iron deficiency.
So, if you think that you may be at risk of having low iron levels without being anemic, maybe you'd like to try Active Iron 25mg! If so, please complete the short survey below to evaluate if you are an appropriate candidate.
Please note that this product should be taken for 10 days. Only individuals who are currently using an iron supplement (not to treat anemia) or who need to increase their iron intake should participate in this program.
If you are not currently using an iron supplement or do not need to increase your iron levels, please do not apply to this product review opportunity.
This survey is to help evaluate potential to participate in this program and has not been clinically validated. It is not intended to diagnose iron deficiency or any other medical condition and should not replace consultation with a healthcare professional. If you have symptoms or concerns, please speak with your healthcare provider.
Opportunity is open to residents of Canada only.
WELIVA is a registered trademark of Norwell Consumer Healthcare Inc.
The Active Iron logos are trademarks of Solvotrin Therapeutics Ltd, used under license.
1. Lopez et al., Iron Deficiency Anaemia, Lancet 2016; 387:907-16
2. Cooper, M. et al. (2023). Population iron status in Canada: Results from the Canadian Health Measures Survey 2012–2019.
3. Tolkien, Z. et al. (2015). Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta Analysis. PLOS ONE. DOI:10.1371/journal.pone.0117383
